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ABSTRACT 
Pharmaceutical and Personal Care Products (PPCPs) are a large, diverse 
group of emerging contaminants comprised of pharmaceuticals, plasticizers, 
detergents, and insecticides.  Studies have shown that PPCPs are entering aquatic 
environments, wastewaters, and water supplies.  The occurrence of these PPCPs 
has generated concern resulting in proposed federal legislation that could require 
control, monitoring, and treatment of Pharmaceutical and Personal Care Products 
by Publicly Owned Treatment Works (POTWs).  This study evaluated the 
potential financial impact this proposed legislation could have on U.S. POTWs 
using City of Mesa, Arizona as a model POTW.  The current laws concerning 
PPCPs as well as the proposed legislation were described.  The proposed federal 
legislation would create investigational studies about PPCPs.  The studies could 
lead to regulations concerning the control, monitoring, and treatment of PPCPs by 
POTWs.  The potential financial costs of the following strategies were assessed: 
multiple barriers concept for PPCP control or prevention programs by POTWs, 
PPCP monitoring of wastewater, and upgrading POTW treatment technology for 
PPCP removal.  Study results found no new wastewater treatment technologies 
were economically suitable for POTWs, however, community education and 
programs such as Household Take-back programs could be financially viable. 
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Chapter 1 
Introduction 
Removal of contaminants from water and wastewater has been a concern 
for generations.  As regulatory and legislative needs change and create more 
stringent standards concerning the discharger’s quality of effluent, the need for 
innovative water and wastewater technology has become a necessity.  With water 
becoming a scarcity in many parts of the United States, the use of technologies for 
reclaimed water reuse, for recharging of effluent into aquifers, and for the 
production of a high quality effluent is needed to prevent potential contamination 
of water supplies and aquatic environments (Foster & Chilton, 2004).  More 
recently, concerns have surfaced on national and global scales about a group of 
emerging contaminants known as Pharmaceutical and Personal Care Products 
(PPCPs) in water supplies, aquatic environments, and wastewater discharges 
(U.S. Environmental Protection Agency, 2011).  The appearance of PPCPs in the 
environment poses an array of potential problems (Daughton, 2004).   
The U.S. EPA has classified PPCPs as emerging pollutants and identifies a 
need for their further study (U.S. Environmental Protection Agency, 2010).   
Pharmaceuticals and Personal Care Products, as defined by the U.S. EPA, are 
“any product used by individuals for personal health or cosmetic reason or used 
by agribusiness to enhance growth or health of livestock” (U.S. Environmental 
Protection Agency, 2010).  PPCPs are emerging pollutants that make-up a very 
broad and diverse collection of substances, as illustrated in Table 1.  PPCPs are a 
complex mix of thousands of chemical substances with myriad problems.    The 
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list of PPCPs is comprised of thousands of chemical substances, including 
prescription drugs, veterinary drugs, and over-the-counter (OTC) drugs, 
fragrances (synthetic musk), cosmetics, sun-screen agents, diagnostic agents, 
nutraceuticals (e.g. vitamins), illicit drugs, growth enhancing chemicals used in 
livestock operations and antimicrobials (U.S. Environmental Protection Agency, 
2010).   
Table 1: Examples of Pharmaceutical and Personal Care Products reported by 
literature to appear in wastewater streams (Rosal, Aguera, Fernandez-Alba, & 
Rodriguez, 2010). 
Pharmaceuticals   
   Drug Class   Examples  
 
   Antidepressants   Fluoxetine, Citalopram 
   Anti-inflammatory  Ibuprofen, Naproxen, Declofenac 
   Antibiotics   Penicillin, Sulfamethoxazole 
   Antiepileptic   Carbamazepine 
   Beta blockers   Atenolol, Metoprolol 
   Lipid regulators   Bezafibrate, Gemfibrozil 
   Illicit drugs   Cocaine, Amphetamines 
   Hormones   Estrone, Estradiol 
   Psychiatric   Diazepam 
Personal Care Products   
Sunscreen   Benzophenone 
Musk Fragrances   Tonalide, Galaxolide 
Stimulants   Caffeine, Nicotine 
Antimicrobials   Triclosan, Manadelamide 
Endocrine disruptors  Bisphenol  A, Octylphenol 
Preservatives   Parabens, BHA 
Insect repellant   DEET    
Detergents   Phosphates 
 
The presence of PPCPs in our water has generated concern.  Some studies 
on aquatic environments have found the presence PPCPs and have documented 
problems such as behavioral modification (Fong, 1998) and reproduction in 
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aquatic wildlife (Esplugas, Bila, Krause, & Dezotti, 2007).  The documentation of 
PPCPs in aquatic environments has generated concern for what possible problems 
PPCPs could have on human health.  Humans have been contributing PPCPs to 
the water supply for generations but the sheer volume and diversity (refer to Table 
1).  The long term effect of PPCPs consumption at low concentrations on humans 
is relatively unknown.  The problem of PPCPs is not being addressed.  Currently, 
no one agency or law addresses the problem of PPCPs.  There are no current 
PPCP regulations requiring the monitoring, control, or treatment by POTWs.  
There are just too many unknowns with PPCPs in our water sources and aquatic 
environments for us to overlook any longer. 
Pharmaceutical and Personal Care products enter the wastewater stream, 
aquatic environment, and water supply in numerous ways.  The U.S. EPA has 
found that PPCPs can enter the environment through washing, swimming, 
bathing, excreting or disposal down into domestic wastewater collection systems 
or landfills, wastewater treatment wastes or recharging water, leaching from 
landfills improperly engineered, by treated livestock, agriculture, and aquaculture. 
The variety of products comprised on the list of PPCPs creates a large list of 
potential sources, as seen in Figure 1, found by the U.S. EPA for potential 
releases. The Origins and Fate of PPCPs in the Environment (Daughton, 2006) 
created by the U.S. EPA provides a visual image that represents potential release 
sources and fate of PPCPs, as illustrated in Figure 1.  The numerous ways that 
PPCPs enter the environment makes prevention and treatment of PPCP 
contamination in the environment a potential problem. 
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Historically, to prevent potential problems from contamination, the 
principles behind the “multiple barriers concept” have been utilized to protect 
water sources and aquatic environments.  The multiple barriers concept is an 
approach of instituting multiple barriers throughout the water cycle process to 
prevent pollutant contamination from source to discharge (Spellman, 2003). An 
integrated approach of placing barriers begins with protection of source water 
through the water conveyance and water treatment to water distribution and into 
wastewater treatment and finally to discharge.  The implementation of multiple 
barriers throughout the system starts with understanding the water cycle process, 
locating potential risks and installing barriers to eliminate or minimize pollutants 
impact.  To protect source water, pollution protection programs including 
legislation such as the Safe Drinking Water Act and its amendments are used as 
barriers.  Preventing the risk of pollutant contamination is less expensive than 
having to remove pollutants with treatment processes.  To manage the risk of 
contamination in water treatment, barriers are placed in the treatment process to 
remove contaminants from source water using the most effective treatment 
processes and disinfection to produce high quality water.  In water conveyance, 
barriers placed in the infrastructure are used to prevent cross contamination with 
non-potable.  The monitoring of source water and its distribution process would 
help to detect and fix problems before contamination gets out of control.  
Monitoring would measure the effectiveness of treatments and problems in 
distribution.  The wastewater treatment barriers allow for the most effective 
treatment technologies to control pollutants and protect public health.  A final 
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barrier used to protect water involves consumer awareness.  An important element 
contributing to the multiple barriers concept is preventing pollutant contamination 
by providing the consumer with education and to encourage the consumer’s 
participation in pollution prevention. 
 
Figure 1: Sources for PPCPs entry into environment (Daughton, 2006). 
 
The discharging of wastewater from wastewater treatment facilities is a 
concern for spreading the contamination of PPCPs.  Current barriers utilized to 
prevent contamination by POTWs are treatment, monitoring and compliance.  The 
Clean Water Act, 33 U.S.C. §1251 et seq., dictates to the Publicly Owned 
Treatment Works (POTWs) under the National Pollution Discharge Elimination 
System (NPDES); a permitting program for point-source dischargers, the type of 
treatment processes necessary to meet their regulatory compliance parameters of 
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their effluent.  In the United States, the majority of the POTWs are in need of 
upgrades due to the fact they were constructed over twenty years ago, (U.S. 
Environmental Protection Agency, 2008) so current use of innovative technology 
may be considered limited.   
Along with an aging wastewater infrastructure, there is a national and 
global concern for a category of environmental pollutants that have gone virtually 
overlooked known as Pharmaceuticals and Personal Care Products (PPCP).  
PPCPs are not directly regulated by any one agency or law and are being well 
documented in studies of POTWs, aquatic environments and water supplies.  The 
appearance of PPCPs in the environment poses an array of potential problems. To 
address these problems, federal legislation requiring monitoring, prevention, and 
treatment of PPCPs by wastewater treatment facilities in the United States has 
been proposed. 
Goal and Objectives of the Study 
The goal of this study was to provide an assessment of the potential 
financial impact of proposed federal legislation concerning Pharmaceutical and 
Personal Care Products removal from the wastewater stream on a POTW.  The 
City of Mesa, Arizona was used as a model municipality to assess the potential 
impacts of proposed regulations on typical POTWs.   
 
 
7 
 
The objectives of this study were: 
1.)  Identify and examine the current laws and proposed federal 
legislation concerning Pharmaceutical and Personal Care 
Products for a POTW. 
2.) Examine the potential financial effects of implementation of 
different treatment technologies and prevention practices. 
 
Scope of Study 
The study takes into account publicly available data and sources 
which were assumed to be accurate and complete.  All published sources 
used in the project were assumed to be correct, complete, and accurate.  
This study utilized literature reviews, conference findings, and published 
reports for analysis of potential use of technology.  The financial costs 
were limited to information from peer reviewed journal articles, U.S. EPA 
studies, and commercial manufacturers’ brochures and websites.  
Assumptions for financial costs were extrapolated from existing current 
cost of technologies researched from peer reviewed journals and 
manufacturers’ brochures, and salaries from The City of Mesa Human 
Resource Department .  The study covers a time span of 2009, 2010, and 
2011.   
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Chapter 2 
Literature Review 
Humans have used products classified as PPCPs for generations so the 
presence in the environment is not a sudden appearance.  The major concern is the 
sheer volume of PPCPs being released into the environment and into wastewater 
streams and with extremely diverse physical and chemical properties (Rosal, 
Aguera, Fernandez-Alba, & Rodriguez, 2010).  Many of the PPCPs are bioactive 
and persistent in the environment and are passing through POTWs (Kasprzyk-
Hordern, Dinsdale, & Guwy, 2009). The removal method and efficiency of 
removal of PPCPs depends on many factors such as type of chemical substance, 
chemical structure, acidity, volatility, and sorption potential (Carballa, Omil, & 
Lema, 2005).  PPCPs can be polar and have small molecular weights which can 
be removed through some wastewater treatments (Kimura, Hara, & Watanabe, 
2007) but not all can be removed by the same treatments with equal removal 
efficiencies.  
Pharmaceuticals and Personal Care products, such as hair dyes, 
antimicrobial products, fragrances, sunscreen, soaps, shampoo and dental care 
needs, enter the wastewater stream and aquatic environments through showering, 
washing, and swimming (Ternes, Joss, & Siegrist, 2004).  The appearances of 
antimicrobials, in aquatic environments, are a concern due to their environmental 
persistence (Heidler & Halden, 2009).  The U.S. federal guidelines for disposing 
of unused and expired pharmaceuticals are that they flush them down the sewer 
unless otherwise stated on the label (Office of National Drug Control Policy, 
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2009).  The Federal Government recommendation is that if not flushable that a 
take-back program or community collection program is to be utilized.   
Another factor for humans adding PPCPs into our wastewater stream is 
that many pharmaceutical drugs are not completely metabolized by the human 
body and are thus excreted into the wastewater stream (McGovern & McDonald, 
2003).  As much as 50-90% of drugs can be excreted unchanged or as metabolites 
into the environment (McGovern & McDonald, 2003).  These metabolized or 
partially metabolized pharmaceuticals are typically bioactive and can accumulate 
in the environment.  A trend to use sludge from POTWs on agricultural land, 
recharging of reclaimed water into aquifers and the reuse of reclaimed water for 
agricultural irrigation opens up avenues for potential contamination of U.S. soils 
and waters.  Hospitals disposing of pharmaceuticals also contribute to the 
wastewater stream (Ternes, Joss, & Siegrist, 2004).  The fate and occurrence of 
PPCPs in aquatic environments is documented and being researched in published 
reports but the potential for chronic problems is high.  The U.S. EPA states that 
the environmental transport and fate of PPCPs are from terrestrial domain to 
aqueous domain (Daughton C. G., 2006).  Thus, humans are adding pollutants to 
the land that are ending up in aquatic environments (for example see Figure 1). 
Impact on Human Health and Aquatic Life 
The impacts on human health by PPCPs even at low concentrations are still 
relatively unknown.  PPCPs are being detected in the aquatic environment at 
extremely low levels of concentrations in the parts per trillion (ppt) and parts per 
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billion (ppb) levels (Jasim, Irabelli, Yang, Ahmend, & Schweitzer, 2006).  The 
potential problems with the detection of these substances at low concentrations 
are that most pharmaceuticals are designed to be effective at low levels.  The 
consequences of releasing a potentially bioactive, and not completely metabolized 
substance, into the environment are potentially significant.  Some of the effects 
that are appearing in humans exposed to endocrine disrupting compounds are 
sperm reduction in males, early maturation in females, and an increased incidence 
of breast, testicle and prostate cancer (Esplugas, Bila, Krause, & Dezotti, 2007).  
The presence of antibiotics in water has created a concern of creating of 
antimicrobial resistance in microbes and the population.  The appearance of 
PPCPs in drinking water supplies has generated a concern about long term effects 
of consumption at low concentrations on the developing fetus and reproduction of 
humans (McGovern & McDonald, 2003).  
The presence of PPCPs in aquatic environments in the U.S. has been well 
documented.  Studies have shown that trace levels of PPCPs are making it 
through our wastewater treatment facilities and entering the aquatic environment 
and the water supply (NYC EPA, 2010).  A nationwide survey conducted by the 
U.S. Geological Survey in 1999, found the presence of pharmaceuticals, 
hormones and other organic contaminants in 139 streams from 30 states 
(Reynolds, 2003).  The US Environmental Protection Agency (US EPA) 
conducted a PPCP study by sampling the influent and effluent of nine POTWs 
having varying treatment levels from around the United States. The study found 
that out of seventy-two PPCPs analyzed, seven PPCPs were found in both influent 
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and effluent (EPA, 2009, p. 27).  One study conducted on the influent of a 
drinking water facility found that of 113 organic compounds made up of 
pharmaceuticals, detergents, pesticides, steroids, etc., 45 of the compounds were 
identified in samples (Stackelberg, Gibs, Furlong, Meyer, Zaugg, & Lippincott, 
2007).   
Although the potential harm to humans of exposure to low concentrations 
of PPCPs is still uncertain, the effects on aquatic life are well documented.  
Studies have shown that fish exposed to hormones in their environment are 
causing the feminization of male fish (Natural Sciences and Engineering Research 
Council, 2008).  The exposure to a mixture of antidepressant drugs in the fish 
population showed behavioral alteration that could result a decrease in predatory 
avoidance behavior (Painter, et al., 2009).  Another study showed that exposure of 
aquatic life to antidepressants altered spawning patterns mussels (Fong, 1998).  
Problems with reproduction of several species of fish, birds, reptiles and 
mammals have also been seen (Esplugas, Bila, Krause, & Dezotti, 2007).  The 
problems seen in aquatic and terrestrial animal life should be a trigger for humans 
to investigate the problems PPCPs can pose to humans. 
 
Legislative Standards 
Current Legislative Standards 
The Federal Water Pollution Control Act, also commonly known as the 
Clean Water Act (CWA), 33 U.S.C. §1251 et seq., along with its amendments, 
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regulates discharges of pollutants into the waters of the United States and the 
quality standards for surface waters. Under the CWA, EPA has implemented 
pollution control programs such as The National Pollutant Discharge Elimination 
System (NPDES) permit program which controls point source discharges into 
waters of the U.S.   Industrial, municipal, and other facilities must obtain permits 
if their discharges go directly to surface waters (National Pollutant Discharge 
Elimination System (NPDES), 2009). The NPDES can be administered at the 
state level upon authorization or at the federal level by the United States 
Environmental Protection Agency (US EPA). The State of Arizona has chosen to 
administer its own program called the Arizona Pollutant Discharge Elimination 
System (AZPDES) -a permit program run through Arizona Department of 
Environmental Quality (ADEQ) (Arizona Department of Environmental Quality, 
2011).  Wastewater treatment in the United States is primarily determined by the 
CWA and its amendments. Permits are issued under the CWA as a program called 
NPDES.  These permits determine the type and degree of treatment needed to be 
performed on the wastewater to prevent future deterioration of water quality from 
discharges (Congress & Copeland, 2010).  As far as PPCPs are concerned, 
currently, there is no other federal legislation in place that requires any 
monitoring, treatment or prevention of PPCPs. 
Proposed Federal Legislation  
H.R. 1262: The Water Quality Investment Act of 2009 
Federal House Bill H.R. 1262 proposes to amend sec. 104 of Federal 
Water Pollution Control Act (33 U.S.C. 1254) by adding Title VI sec. 6001 
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subtitled Presence of Pharmaceuticals and Personal Care Products (PPCP) in 
waters of the U.S. This section of the bill would require the EPA Administrator to 
conduct a study of the presence of Pharmaceuticals and Personal Care Products in 
waters of the U.S. (H.R. 1262, 2011).  The contents of the study must include 
identifying PPCPs that have been detected in waters of the U.S. and at what 
levels. The study must identify sources, both point and non-point, of PPCPs in 
waters of the U.S. Lastly, the study must identify methods to control, limit, treat, 
or prevent PPCPs in waters of the U.S.  The report must be concluded in 12 
months.  
As of printing, H.R. 1262 had passed in the United States House of 
Representatives. As of March 16, 2009, the bill had been received in the Senate. 
Currently, the bill has been read twice and referred to the Committee on 
Environment and Public Works. 
H.R. 1145: National Water Research and Development Initiative Act of 2009  
 Federal House Bill H.R. 1145, National Water Research and Development 
Initiative Act, in section 9, is a bill that proposes to amend the Water Resources 
Research Act of 1984 to require water resources research and technology 
development to include technical research on prevention and removal of 
contaminants of emerging concern, such as endocrine disrupting compounds 
(EDC), and pharmaceuticals, and personal care products (PPCPs), in water 
resources (H.R. 1145, 2009).  If the bill is promulgated into law, it will require the 
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U.S. EPA to conduct a study of PPCPs within two years to propose possible 
treatment options and sources that will prevent contamination of water sources. 
 As of printing, H.R. 1145, on April 23, 2009, the bill was passed by a vote 
by the House of Representatives.  The last legislative action taken on H.R. 1145 
was that it was received in the Senate and read twice and referred to the 
Committee on Environment and Public Works.   
S.1005: The Water Infrastructure Financing Act 
Federal Senate bill 1005, The Water Infrastructure Financing Act, section 
308 titled Pharmaceuticals and Personal Care Products (PPCP), proposes to 
amend sec. 104 of Federal Water Pollution Control Act (33 U.S.C. 1254) by 
adding definitions and a study concerning Pharmaceuticals and Personal Care 
Products (PPCP) as pollutants. The Administrator in conjunction with the 
National Academy of Sciences is asked to report on the presence PPCPs as 
pollutants in waters of the U.S. The study needs to identify which PPCPs are 
detected and at what levels, and identify point and non-point sources of PPCPs in 
a water of the U.S. (S. 1005, 2011). This bill requires studies to evaluate risks 
associated with PPCPs in waters of the U.S. Based on this assessment, the study 
would detail the technical, economic, and legal feasibility of methods to control, 
limit, treat, or prevent Pharmaceuticals and Personal Care Products (PPCP) from 
contaminating waters of the U.S. The report must be concluded within two years 
of passage of the bill. 
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The most recent legislative progress is that S. 1005 has been reported on 
by Committee. This bill was considered in Committee and recommended to be 
considered by the Senate. It has been placed on the Senate Legislative Calendar 
under General Orders, Calendar No. 109. 
S.1005 bill and H.R.1262 bill are similar in that they both require 
identifying sources, types, and detection levels of PPCPs.  However, S. 1005 goes 
a step further than H.R. 1262 by asking for a study concerning the technical, 
economic, and legal feasibility of methods to control, limit, treat, or prevent 
PPCPs.  The S. 1005 bill would provide more information concerning the 
feasibility of potential PPCP regulations. 
Massachusetts House Bill no. 5023  
In Commonwealth of Massachusetts, House Bill no. 5023 has been 
presented that would create a special commission to study and assess the public 
health threat of having contamination of pharmaceutical and personal care 
products (PPCP) in the water supply. This fourteen member commission is 
assigned to review several topics including statutory and regulatory changes, 
water filtration options, wastewater management, and proper disposal of 
pharmaceuticals (e-Lobbyist LLC, 2011). The commission is required to report 
their results within 12 months of passage of the bill. 
As of printing, the bill has been referred to the Joint Committee on Rules 
on 9/16/2010 under House Bill no. 5023. This House Bill gives authorization for 
the committee on Environment Natural Resources and Agriculture to initiate 
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investigational studies. On 9/16/2010 the bill was discharged to the House 
Committee on Rules who will schedule and make recommendations for 
legislation (The Commonwealth of Massachusetts , 2011). 
 A description of the current federal laws and regulations concerning 
Pharmaceutical and Personal Care Products and proposed legislature for Publicly 
Owned Treatment Works was provided.  It was found that there are no laws or 
any specific agency that directly regulate Pharmaceutical and Personal Care 
Products by POTWs.  The proposed federal legislation of S. 1005, H.R. 1262 and 
H.R. 1145 would create a regulatory possibility. However, all the currently 
proposed federal legislations concerning PPCPs would simply initiate studies.  
These PPCPs studies would provide educated information for making decisions 
concerning regulations and laws.  Ultimately though, the proposed federal 
legislation concerning PPCPs for POTW would require no monitoring, 
recordkeeping, or establishment of treatment standards. The implication of these 
bills is that control or prevention, treatment, and monitoring of Pharmaceuticals 
and Personal Care Products (PPCP) of our wastewater may be in sight of being a 
legislative and regulatory possibility. Unfortunately, the proposed legislation does 
not go beyond studies creation or go as far as to require monitoring, or 
establishment of treatment standards or end of pipe discharge standards. 
Wastewater Treatment Processes 
A POTW employs different methods or types of treatment depending on 
the characteristics of the influent and the regulatory requirements of the effluent 
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discharges. The purpose of a POTW is to remove contaminants and nutrients from 
the raw wastewater which is done through physical, chemical and/or biological 
treatment processes to produce water that is usable. The multiple barriers concept 
is employed at every step or stage in the wastewater process.  A POTW can be 
divided into several stages: preliminary, primary, secondary, tertiary treatment, 
and disinfection, as illustrated in Figure 2. Preliminary treatment utilizes a 
physical removal process to remove large solids from the entering influent. Types 
of preliminary treatments that can be used are coarse or medium screening, odor 
control, shredding of solids, flow measurements, and grit removal (Water 
Environment Federation, 2008). 
 
Figure 2: An example of the wastewater treatment process (Center for 
Sustainable Systems, University of Michigan, 2009) 
 
The Water Environment Federation classifies primary wastewater 
treatment to involve the settling of heavy solids and floatable debris (Schnaars, 
2008). Sedimentation tanks (rectangular or circular), skimmers, and primary 
clarifiers are examples of primary treatment methods. 
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Secondary wastewater treatment involves the removal of dissolved and 
suspended biological matter, nutrients, and pathogenic microorganisms (Asano, 
Burton, Leverenz, Tsachihashi, & Tachobanoglous, 2007). The types of 
secondary treatment can vary dramatically. Some examples of secondary 
treatments are activated sludge systems, trickling filters, and rotating biological 
contactors. 
The purpose of tertiary wastewater treatment is to achieve a higher quality 
of effluent beyond the scope achievable by secondary treatment. This stage is a 
polishing stage for the effluent for removal of specific wastewater constituents: 
nitrogen, phosphorus, heavy metals, some suspended solids and dissolved solids, 
before discharging the effluent (Pescod, 1992). Tertiary treatment can involve 
methods such as different types of filtration, activated carbon systems, and 
dechlorination (following disinfection). Disinfection is performed on the 
wastewater to destroy microorganisms. Disinfection can be achieved by means of 
chemical (chlorination or ozonation) or physical agents (ultraviolet systems) 
(Asano, Burton, Leverenz, Tsachihashi, & Tachobanoglous, 2007). Disinfection is 
necessary to prevent the transmission of disease to humans and into the 
environment. 
The initial design of the wastewater treatment plant (WWTP) was not to 
treat or remove PPCP but to remove contaminants harmful to human health. Most 
WWTP in the United States are minimally required to perform secondary 
treatment on their wastewater.  One study found that the conventional wastewater 
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treatment plant is not sufficiently achieving ample elimination of PPCPs from 
effluents (Petrovic, Gonzalez, & Barcelo, 2003).  More research is necessary to 
aid water and wastewater treatment facilities to achieve effective and efficient 
removal of PPCPs because little data is available beyond laboratory research and 
pilot projects. 
 The multiple barriers concept is an integrated approach that follows the 
water cycle to protect water through the implementation of barriers.  The City of 
Mesa can place barriers at the following stages: protection of source water, water 
treatment and wastewater treatment.  Every stage in the process places as many 
duplicated barriers as need to protect, prevent, and treat for pollutants such as 
PPCPs.  The potential problems associated with the introduction of PPCPs can be 
handled in several ways.  The City of Mesa POTWs has implemented multiple 
barriers through their wastewater treatment methods to prevent deterioration of 
water quality, as illustrated in Table 2.  All three water reclamation facilities have 
infrastructure that allows for tertiary treatment of their wastewater so that water 
that is re-used or recharged does not contaminate other waters.  A disinfection 
barrier has been employed by each facility that will help protect public health.    
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Table 2: Summary of the City of Mesa POTWs 
 
The City of Mesa 
 POTWs 
Treatment 
Capacity 
 Treatment 
Types 
  
NWWRP 18 MGD  Preliminary, 
primary 
clarification, 
activated sludge, 
secondary 
clarification, dual 
media tertiary 
filtration, and UV 
disinfection. 
 
  
SEWRP 8 MGD  Preliminary, 
primary 
sedimentation, 
aeration 
basins, 
secondary 
clarification, a 
traveling 
bridge tertiary 
filtration 
system, 
hypochlorite 
disinfection, 
and 
dechlorination 
system. 
 
  
GWRP 16 MGD  Preliminary, 
primary 
clarification, 
anoxic and 
aeration 
basins, 
secondary 
clarification, 
rotating cloth 
disk tertiary 
filtration, and 
UV 
disinfection. 
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Available PPCP Treatment Processes 
 The use of innovative technology to remove pollutants from wastewater 
streams is not new.  However, the innovative technologies currently being 
investigated for removal of PPCPs from wastewater and water supplies are in 
pilot POTW programs, laboratory studies and government research studies.  
Currently, no technology is designed specifically for use by municipal wastewater 
treatment or POTW for removal of PPCPs.  All information about the use of 
innovative technology available concerning removal of PPCPs comes from pilot 
POTW programs, U.S. EPA contracted research, university research, and 
commercial case studies. Some technologies have shown promise in the removal 
of PPCPs under specific study conditions for drinking water and can possibly be 
utilized in wastewater treatment.  The technologies evaluated are Nanofiltration, 
Membrane Bioreactors (MBR), Advanced Oxidation Processes (AOP), and 
Granular Activated Carbon Adsorption (GAC).  
The purpose of this section was to research viable treatment options for 
use at POTWs; however, the research found that no truly viable treatment 
methods currently exist for treating wastewater for PPCPs.  All viable data 
showed that the treatment technology is better suited for drinking water treatment 
due to costs and technology limitations. 
Nanofiltration 
Nanofiltration (NF) is a membrane separation method that operates under 
a pressure driven system.  It is considered an advanced or tertiary treatment 
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method that is utilized following secondary treatments as a polishing step for an 
effluent.  This system type is primarily being used in drinking water treatment but 
only experimentally in wastewater treatment.   
The nanofiltration process utilizes cellulose acetate or aromatic polyamide 
semi-permeable membranes to separate out organics and inorganics from the 
liquid phase (Sutherland, 2009).  It is a pressure driven system that operates at 
between 150-500 psi (Yacubowicz & Yacubowicz, 2005) with membrane pore 
sizes between 0.01-0.2 microns (Metcalf & Eddy, 2003).  The membranes are 
selective which allows some components, such as divalent ions, of a dissolved 
mixture to be rejected by the membrane while water, substances with molecular 
weights below 200 Daltons, and monovalent ions pass through the membrane 
(Sutherland, 2009).  
Nanofiltration can remove a wide variety of substances.  Bacteria and 
some viruses can be removed without creating chlorinated hydrocarbons and 
trihalomethanes (Nicoll, 2001).  Herbicides and pesticides can be removed from 
effluent while allowing dissolved minerals to pass through the membranes 
(Nicoll, 2001) thus retaining minerals necessary for water reused for agriculture.  
The elimination of priority organic pollutants, total dissolved solids (TDS), and 
total suspended solids (TSS) are removed with nanofiltration.  Nanofiltration can 
be used by many different industries like water and wastewater facilities as a 
polishing stage, dairy industry, pharmaceutical, and textile industry. Figure 3 
shows examples of some nanofiltration systems. 
23 
 
 
Figure 3: Examples of nanofiltration systems (Aastropure Systems Private 
Limited , 2011) 
 
Removal Efficiency for PPCPs by Nanofiltration 
The efficiency and effective removal of PPCPs by treatment processes can 
vary dramatically mainly due to the diverse nature and type of substances.  
Nanofiltration has been found to be highly effective in removal of certain PPCPs.  
A 30-90% removal rate for reductions of contaminants with molecular weights 
over 300 g/mol and when combined with ozone a 99% removal rate for some 
could be achieved (Flyborg, 2009) was observed in one study.  Another study 
found that nanofiltration could reduce concentrations of endocrine disruptor 
compounds by 65-85% (Braeken & Van der Bruggen, 2009).  Radjenovic, et al. 
(2007) study found nanofiltration could have about a 95% removal of negatively 
charged pharmaceuticals, such as Declofenac and Sulfamethoxazole, and about a 
90% reduction for positively charged pharmaceuticals, like Metoprolol 
(Radjenovic, Petrovic, Ventura, & Barcelo, 2008).  The use of nanofiltration is 
limited when the level of organics is high making it difficult to utilize in 
wastewater by POTW (Aespach, 2007).  The use of nanofiltration could provide a 
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good option depending on the characteristics of the influent and standards for 
effluent.   
The Costs for Nanofiltration 
The costs for a nanofiltration can vary dramatically depending on the daily 
treatment flow and characteristics of the influent.  The replacing of the 
membranes for nanofiltration, which is necessary about every 3-7 years, can be 
expensive especially if there is excessive membrane fouling which may be 
decreased by adding a pretreatment.  A nanofiltration treatment system can be 
added for approximately $0.30—$0.50/1,000 treated gallons depending on water 
quality, water temperature and rejection needs for a drinking water system (Cluff, 
2002).   The costs to implement nanofiltration for a POTW would extremely 
expensive and not cost efficient for municipalities.   
Membrane Bioreactors 
The Membrane Bioreactor (MBR) process is considered to be an advanced 
water treatment process.  MBR combines an activated sludge system with solids 
removal by a filtration membrane separation system like microfiltration (U.S. 
Environmental Protection Agency, 2007).   MBR membranes eliminate the need 
for secondary clarifiers and sand filters for solid-liquid separation (U.S. 
Environmental Protection Agency, 2007).  The pores of the membranes are used 
to filter water from the Mixed Liquor Suspended Solids (MLSS) process leaving 
solids in the reactor in the mixed liquor and filtered water exiting as a secondary 
effluent (U.S. Environmental Protection Agency, 2008).  MBR generates less 
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sludge than conventional systems due to high solids retention time (SRT) and 
high MLSS concentrations (Water Environment Federation, 2008). 
Membranes used in MBRs are made of organic polymers such as cellulose 
or inorganic materials such as ceramics (U.S. Environmental Protection Agency, 
2007).  Several types of membranes can be used: hollow fiber, plate frame, or 
pleated cartridge; depending on the necessary application (U.S. Environmental 
Protection Agency, 2008).  The membrane elements are assembled into modules 
then into cassettes which are inserted into process trains which are then integrated 
with the bioreactor (Daigger, 2005).  MBR systems are designed as submerged 
membrane reactors, where the membrane module is immersed in the aeration 
tank, or externally located in a separate compartment as seen in the Figure 4.  A 
typical MBR system, as seen in Figure 4, has a pretreatment process to remove 
debris through screening and grit removal before entering the aeration tank with 
the membranes, then the processed water is pumped to disinfection and mixed 
liquor is recirculated, if necessary, for denitrification (Chapman, Leslie, & Law, 
2001). 
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Figure 4: Diagram of the Membrane Bioreactor Treatment Process (City of Oak 
Harbor, Washington, 2011) 
 
Removal Efficiency for PPCPs by MBR 
 The use of Membrane Bioreactors has shown promise for removal of a 
wide range of PPCPs in several laboratory studies.  MBR demonstrated that it was 
able to handle the removal of pharmaceuticals with complex structures as long as 
a long solids retention time (SRT), i.e. 65 days, was utilized (Kimura, Hara, & 
Watanabe, 2007).  The same study demonstrated that with long SRTs it was able 
to almost completely eliminate some anti-inflammatory drugs like naproxen and 
ketoprofen (Kimura, Hara, & Watanabe, 2007).  The reduction of hormones with 
MBR was greater than 70% for estrone and an estradiol (Spring, Bagley, & 
Andrews, 2007).  Another study utilizing MBR resulted in the attenuation of 87-
99% for eight analgesic and anti-inflammatory drugs like naproxen, diclofenac, 
mefenamic acid (Radjenovic, Petrovic, & Barcelo, 2007).  Some antibiotics, such 
as ofloxacin, sulfamethoxazole and erythromycin, were also shown to be reduced 
by the use of MBR at an elimination rate of 60-90% (Radjenovic, Petrovic, & 
Barcelo, 2007). Some challenges with MBR are that it requires extensive 
membrane cleaning, handling of membrane fouling and eventual membrane 
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replacement (U.S. Environmental Protection Agency, 2007).  The utilization of 
MBR may be beneficial for removal of several kinds of PPCPs on a small scale 
but not on the large scale of POTWs.  
The Costs for MBR 
The capital costs and operational costs for a MBR system varies based on 
design capacity, treatment standards for effluent and characteristics of influent.    
The Xpress™ membrane biological reactor (MBR) packaged plant from Siemens 
Water will cost, including installation, approximately. $7 - $20 per gallon treated 
(Siemens Water Technologies, 2011).  For a large city with a POTW treating 
millions of gallons of wastewater it would not be feasible.  The U.S. EPA found 
that the operating cost of a MBR system to be $1.77 per 1,000 gallons treated and 
capital cost for MBR at $12 per gallon treated (U.S. Environmental Protection 
Agency, 2007).  The average replacement of the membranes is about 7 years and 
can inflate the start-up cost due to the expensive nature of the membranes. 
Advanced Oxidation Processes (AOP)  
Advanced Oxidation Processes (AOP) are innovative treatment processes 
that use a combination of ozonation systems, ultraviolet systems and hydrogen 
peroxide systems to treat water.  AOPs are used to decompose unwanted chemical 
and organic compounds, total organic carbon (TOC), chemical oxygen demand 
(COD) and biological oxygen demand (BOD) from water (ESCO International, 
2010).   AOPs do not produce additional by-products like chlorine residuals or 
sludge as conventional secondary wastewater treatment systems can.  The 
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combination of ozonation systems, ultraviolet (UV) systems and hydrogen 
peroxide systems seem to work more efficiently than using any one system by 
itself (AWWA, 2011).  Examples of ways AOPs can be combined for use are 
ozone and peroxide, UV systems and peroxide, and ozone and UV systems. The 
use of AOP systems can be flexible which can be used to suit the needs of a 
specific application and are fully automated which can reduce capital and 
operating costs (ESCO International, 2010). 
All three of the AOPs are destruction processes that utilize oxidization as a 
means of eliminating organics in water. Target contaminants in wastewater are 
exposed to oxidizers (ozone), in combination with UV light and/or hydrogen 
peroxide (H2O2) such that complete mineralization is achieved; the final products 
of the oxidation are carbon dioxide, water, and salts (Van Deuren, Lloyd, 
Chhetry, Liou, & Peck, 2002).   In a UV/ozone system, the dissolved ozone 
absorbs the UV light and the ozone reacts with it to form the hydroxyl radical, a 
strong oxidant (U.S. Environmental Protection Agency, 2011).  In an 
ozone/hydrogen peroxide system, an aqueous solution H2O2 is injected into a 
second ozone contactor chamber where the elimination of contaminants like 
PPCPs occurs (U.S. Environmental Protection Agency, 2011).  In the UV/ 
hydrogen peroxide system, the water is exposed to a low pressure or medium 
pressure UV light which is used to catalyze the formation of the hydroxyl radical 
following a reaction with the contaminants (U.S. Environmental Protection 
Agency, 2011).  Each of the AOP systems are placed after the conventional 
treatment , such as filtration, is performed but prior to a disinfection system, if 
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necessary.  The systems are created with a dosing system for the hydrogen 
peroxide, UV lamps or ozone generator, and control systems (U.S. Environmental 
Protection Agency, 2011). 
 
 
Figure 5: An example of an ozone and UV AOP system (ESCO International, 
2011) 
Removal Efficiency for AOP 
The use of AOPs is an innovative technology that has had some success 
with removal of PPCPs under laboratory conditions.  All the studies used varied 
levels and concentrations of ozone, hydrogen peroxide and UV to achieve said 
study results.  A bench-scale study using wastewater found that caffeine, 
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naproxen, and DEET were removed at greater than 80% efficiency and more than 
90% for acetaminophen (Kim & Tanaka, 2010).  Another study found that using 
AOP after a biological treatment was able to remove galaxolide (fragrance musk), 
diclofenac, and carbamazepine at greater than 90% removal efficiency (Suarez, 
Carballa, & Omil, 2008).  In a laboratory study using UV/ H2O2 found a high 
level of removal of carbamazepine and its intermediates (Vogna, Marotta, 
Andreozzi, Napolitano, & d'Ischia, 2004).  Another study utilizing Ozone/ H2O2 
on pharmaceutical wastewater demonstrated a greater than 90% removal of 
several antibiotics such as sulfamethoxazole.  A greater than 90% removal was 
seen in a study using AOPs with ozone in compounds such as pesticides, anti-
inflammatory, hormones, antibiotics, and antiepileptic drugs (Esplugas, Bila, 
Krause, & Dezotti, 2007). A problem with AOP systems is that TOC levels in 
wastewater are so high they need to be dramatically reduced for AOP systems to 
be effective (Yamada & Tsuno, 2006).  The use of AOP technology can achieve 
high removal efficiency for a variety of PPCPs in the laboratory for purer waters 
but not suitable for wastewater. 
The costs for AOP 
 The costs for AOPs are specific to each project and effluent standards.  
The design parameters are dependent on flow rate, influent characteristics and 
removal efficiency necessary.  An AOP system can range from 1.3 million to 1.7 
million dollars for capital costs and operating costs running around $ 0.86 to 
$4.47 per 1000 gal. (Lehr, 2004).  One study found that depending on type of 
contaminants to be removed, an AOP system costs in the range of $0.68 -1.14 per 
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1000 gal for an UV/ H2O2 and Ozone/ H2O2 system for drinking water but as high 
as $7-11 per 1000 gal for some commercial needs (Mahamuni & Adewuyi, 2010).    
Granular Activated Carbon Adsorption  
Granular Activated Carbon Adsorption (GAC) is classified by the U.S. 
EPA as a tertiary treatment for drinking water.  GAC works by using a natural 
process called adsorption.  Adsorption occurs when molecules of a dissolved 
compound collect and adhere to the surface of an adsorbent solid, in this case 
activated carbon (Shepherd, 1992).  The activated carbon is created by increasing 
the size of the pores in the carbon particles thus increasing the surface area 
making it more effective in removing organic particles (Water Environment 
Federation, 2008).  Granular Activated Carbon systems have been utilized to 
remove a number of substances including non-polar organics, halogens, and 
inorganics such as nitrogen, sulfides and heavy metals (U.S. Environmental 
Protection Agency, 2000). 
The GAC system is made up of several parts.  The system involves a 
carbon contactor, carbon storage (for virgin and spent), carbon transport system 
(piping), and carbon regeneration system.  Water is pumped into a carbon 
contactor that could be a lined steel column or a steel or concrete rectangular bed 
in which the activated carbon is placed to form a filter bed (U.S. Environmental 
Protection Agency, 2000).  The carbon contactors are usually placed in series or 
parallel to minimize the constant use of any one contactor or to minimize the 
impact of shutting one off for cleaning.  At a constant rate the water passes 
through the column or bed, creating an accumulation of unwanted substances in 
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the filter after the water has maintained the necessary amount of contact time 
needed for removal.  The effluent is then pumped into the disinfection step.  
Placement of the GAC unit depends on the secondary treatment process being 
used.  If a biological process is used then the GAC should be placed after 
filtration but prior to disinfection (U.S. Environmental Protection Agency, 2010).  
If a physical-chemical process is used for secondary treatment then the GAC 
system would follow the chemical clarification and filtration systems but prior to 
disinfection (U.S. Environmental Protection Agency, 2010).  GAC can be 
incorporated in an existing facility fairly easily and with minimal space 
requirements. 
Regeneration of spent carbon can be handled by facilities in several ways.  
The facilities can have on-site regeneration by steam, thermal and chemical 
methods or off-site regeneration systems or by landfill disposal of waste spent 
carbon with new carbon being replaced (U.S. Environmental Protection Agency, 
2010). The carbon regeneration performed on-site seems to be the most 
economical if available. 
 
Figure 6: An example of carbon contactor column (Cannon, 2011) 
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Efficiency rate of removal of PPCPs by GAC 
The US EPA states that the use of GAC is a successful method of tertiary 
treatment system for drinking water.  A study found that utilizing GAC reduced 
bisphenol A and DEET by 25-75% (Stackelberg, Gibs, Furlong, Meyer, Zaugg, & 
Lippincott, 2007).  The same drinking water study also found a reduction of 90% 
of carbamazepine after GAC (Stackelberg, Gibs, Furlong, Meyer, Zaugg, & 
Lippincott, 2007).  Another bench-scale study found a greater than 90% reduction 
of estradiol (Bundy, Doucette, McNeill, & Ericson, 2007).  A research project of 
two water reclamation plants and one wastewater treatment plant analyzed 
effluents and found 70% reduction for Butylated hydroxyanisole (BHA) and 
carbamazepine when GAC was employed (Soliman, Pedersen, Park, Castaneda-
Jimenez, Stenstrom, & Suffet, 2007).  Thus the use of GAC can be very useful for 
removal of several kinds of PPCPs. 
A challenge for the use of a GAC system by POTWs is that it requires a 
low suspended solids concentration for it to be effective (U.S. Environmental 
Protection Agency, 2000) which is quite high in wastewater. The variations in 
temperature, pH, and flow rate can also affect GAC adsorption (U.S. 
Environmental Protection Agency, 2000).  These problems make the use of GAC 
systems in POTW a problem. 
The costs for GAC 
The factors that influence the costs for a GAC are dependent on a number 
of factors such as flow rates, contaminant types, and quality standards for 
effluent.   The treatment costs for GAC application, in drinking water, can be as 
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low as $0.25 per 1,000 gallons, with a median value of approximately $0.60 per 
1,000 gallons (PennWell Inc., 2011). The operating costs for drinking water 
facilities with GAC treatment can be as low as $0.50 per 1,000 gallons with $1.10 
per 1,000 gallons as the median (PennWell Inc., 2011).  Information concerning 
costs for GAC systems at POTWs is limited due to the fact that it is not utilized 
for removal of PPCP except on a small scale for laboratory and research studies. 
The implementation of any of these technologies into a water treatment or 
wastewater treatment system is highly specific to the facility, given the 
characteristics of the influent and the necessary standards of the effluent.  The 
economic cost is important to municipalities as much as achieving a high quality 
effluent, however, an evaluation of all the factors can generate a good median.   
The purpose of this section was to research possible viable treatment 
options for use at POTWs; however, the research found that no truly viable 
treatment methods currently exist for treating wastewater for PPCPs.  All viable 
data showed that the treatment technology is better suited for drinking water 
treatment due to costs and technology limitations. 
Existing Infrastructure of POTWs of the City of Mesa, Arizona 
The City of Mesa, Arizona is located approximately fifteen miles east of 
Phoenix in Maricopa County, Figure 7. The City of Mesa is the third largest city 
in Arizona with a population about 460,000 people ( Arizona Department of 
Commerce, 2009). The city covers an area of approximately 133 square miles. 
Figure 7 shows the location of the City of Mesa, AZ on the map. 
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Figure 7: Location of City of Mesa, Arizona in the State of Arizona (Sperling, 
2005) 
 
The water resources used by the City of Mesa come from surface waters 
such as The Salt River Project canals (SRP), and Central Arizona Project canals 
(CAP) as well as groundwater (Western Resource Advocates, 2010). The City of 
Mesa owns and operates three wastewater treatment facilities also called water 
reclamation plants: Northwest Water Reclamation Plant (NWWRP), Southeast 
Water Reclamation Plant (SEWRP), and Greenfield Water Reclamation Plant 
(GWRP). The City of Mesa POTWs has a combined total treatment capacity of 42 
MGD liquids reclamation. Each plant is classified as a Publicly Owned Treatment 
Works and as a major facility under The National Pollutant Discharge Elimination 
System. A description of wastewater treatment for each of the three existing 
POTWs is summarized in Appendix A.  Currently, all three plants owned and 
operated by the City of Mesa are required to do analytical testing per their 
respective permits. However, no monitoring or testing is performed or required 
for Pharmaceutical and Personal Care Products (PPCP) by the City of Mesa. The 
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City of Mesa has a 100 year water supply requirement, thus the City of Mesa 
reuses and recharges the effluent from these facilities to maintain compliance with 
that standard.  The SEWRP and NWWRP produce about 13,000 acre-feet yearly 
of reclaimed water which is used for non-potable uses such as irrigating golf 
courses and landscape irrigation (City of Mesa Utilities Department Resources 
Division, 2004).   
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Chapter 3 
Methodology 
The goal of this study was to assess the impact federal legislative changes 
concerning Pharmaceutical and Personal Care Products in wastewater stream 
would have on a typical Publicly Owned Treatment Works.  The focus of the 
study was on the proposed federal legislation impact on a typical POTW that is 
represented by the City of Mesa.  In order to gather the necessary data, the 
researcher utilized the descriptive method for describing the current situation. 
Data Collection and Analysis 
Objective One 
Objective one was achieved by first identifying the current laws and 
proposed federal legislation concerning PPCPs through the search engine Google.  
The criterion used to search in Google was Pharmaceutical and Personal Care 
Products, laws, and POTW.  Also the criterion used was Pharmaceutical and 
Personal Care Products, proposed federal legislation, and POTWs in Google.  The 
U.S. EPA websites associated with water quality and wastewater were used to 
investigate current laws and review published reports.  A search on Govtrack.us 
was performed to examine proposed federal legislation concerning PPCPs. The 
criterion used, on Govtrack.us, was congress, bills, water quality and 
pharmaceutical to locate bills associated with PPCPs and POTWs.   
To describe the proposed federal legislation, Govtrack.us and eLobbyist 
allowed access to actual proposed bill documents for House and Senate bills as 
well as the current status of bills in the legislative process.  An interpretation was 
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performed by a review of the House and Senate bills and then used to extrapolate 
potential impacts from proposed legislation acquired from published documents 
from the State of Arizona, U.S. federal agencies, and public documents. The full 
text of proposed federal legislation for House and Senate bills, acquired from 
eLobbyist and Govtrack.us, was used to interpret and extrapolate the potential 
impact on a model POTW demonstrated by a case study of the City of Mesa’s 
POTWs.  
Objective Two 
Potential Financial Effects: Collection and Analysis  
In order to examine the potential financial effects of proposed federal 
legislation concerning PPCP on a POTW a case study approach was chosen to 
demonstrate the impact through extrapolation of the proposed legislation.  Prior to 
commencing a case study the selection of a model city with POTWs was chosen.  
The City of Mesa, Arizona was selected as the typical city due to its classification 
of a large city with a population of less than 500,000 that had POTWs that could 
be potentially impacted by the proposed PPCP federal legislation.  To select this 
city Google was utilized, in October 2010, with the criterion of large city, POTW, 
population less than 500,000 and Arizona.  The City of Mesa’s website was used 
to document the city’s existing POTWs, wastewater treatment technologies and 
prevention practices.  Arizona Department of Environment Quality (ADEQ) 
provided further documentation and descriptions of the POTWs through permits 
and technology schematics of the existing infrastructure of the City of Mesa that 
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were used for the interpretation of the proposed legislative impact.  A description 
of existing infrastructure was presented to determine whether a need for 
implementation of PPCP removal technology would be required due to proposed 
federal legislation. 
Prevention Practice Potential Financial Effects: 
To demonstrate potential financial effects of implementation of prevention 
practices several tasks were addressed.  One task would be to identify and 
document existing PPCP levels from the City of Mesa’s POTWs.  According to 
POTW permits for the City of Mesa and the City of Mesa’s website, no PPCP 
monitoring or testing is currently being performed.  In order to document existing 
PPCPs in the influent and effluent of their POTW, sampling and testing need to 
be performed.  Sampling costs were calculated and extrapolated from the City of 
Mesa’s human resources website for a wastewater collection operator’s annual 
salary.   
Another task addressed was to determine the costs associated with 
wastewater sample analyses.  According to ADEQ public documents, the City of 
Mesa wastewater laboratory is not certified to perform analysis for PPCPs on 
wastewater samples.  Thus to demonstrate potential financial effects of 
implementation of prevention practices a search was performed on Google to 
locate laboratories that were certified to perform analysis on wastewater samples 
for PPCPs.  The two set of criterion were used in Google.  The first set of 
criterion was PPCP, Arizona, and certified laboratory.  The second set of criterion 
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used was PPCP, wastewater, and certified laboratory.  This researcher selected 
one laboratory with a satellite office in the Phoenix, Arizona area so that costs 
could be calculated without the need for shipping costs for the samples and just 
local transportation costs.  A second certified laboratory was selected whom could 
perform PPCP analysis on the wastewater samples for use as a comparison.   
On October 21, 2011, an e-mail request for a quote for PPCP wastewater 
samples was sent to TestAmerica and Columbia Analytical Services.  The design 
of the e-mail was based on a standard business letter and requested a quote for 
analysis of six wastewater samples for EPA methods 1694, 1698, and 1699. The 
researcher selected six samples for analysis because the City of Mesa has three 
existing POTW with one point for influent and one point for effluent selected.   
The data from quotes documented the estimated costs of wastewater 
analysis for PPCPs and data acquired was used to calculate an average cost of 
PPCP analysis for EPA methods 1694, 1698 and 1699 for all six samples. 
To demonstrate potential financial effects of implementation of setting up 
a PPCP certified laboratory, data was acquired from commercial manufacturers of 
testing equipment websites, current manufacturer brochures and EPA wastewater 
fact sheets.   Costs were extrapolated from published reports from peer reviewed 
journals and EPA wastewater fact sheets for operating and maintenance costs as 
well as commercial manufacturers of testing equipment websites and current 
manufacturer brochures.  The data and costs were then used to extrapolate 
potential financial effects for the City of Mesa. 
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A document review of current EPA standards and research projects 
acquired from published reports, peer reviewed journals, and EPA websites were 
used to document and interpret the need for prevention practices and possible 
technologies for use by POTW for PPCPs.  Arizona Department of Environmental 
Quality (ADEQ) provided AZ NDPES permits of existing POTW infrastructures 
that were used to interpret potential impact on the City of Mesa from the 
implementation of proposed federal PPCP legislation. The City of Mesa’s website 
and State of Arizona public documents, as well as current ADEQ POTW permits 
were used to document current prevention practices. 
Implementation of Treatment Technologies Potential Financial Effects: 
To demonstrate potential financial effects of implementation of treatment 
technologies several tasks were addressed.  First task began with a search for the 
identification of different treatment technologies available for PPCP removal.  
The search was performed at ASU Libraries website through LibaryOne to locate 
peer reviewed journals and books.  The criterion chosen was PPCP removal 
technology and water.  Technology being utilized for PPCP removal, 
experimentally or commercially, were identified through peer reviewed journals, 
U.S. EPA published reports and websites. Also a Google search was performed to 
identify PPCP treatment technologies for use by POTWs.  The criterion chosen 
was PPCP removal technology, POTW and commercial manufacturers.   
Another tasked provided descriptions and specifications of the types of 
PPCP removal technology identified.  The descriptions and specifications were 
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acquired from books, peer reviewed journals and U.S. EPA published reports 
along with commercial manufacturers’ brochures and websites.  Interpretations 
were made and justified from results of comparisons of usefulness, effectiveness, 
and costs of identified PPCP removal technologies for use by POTWs.  The costs 
associated with PPCP available technology were acquired from peer reviewed 
journals, PPCP technology commercial manufactures brochures and their 
websites along with U.S. EPA published reports and EPA technology fact sheets.  
The costs were then extrapolated to demonstrate the potential impacts if 
implemented at the POTWs if deemed useful or economically feasible. 
A snapshot of the available PPCP removal technology provided 
information that allowed for extrapolation of the potential financial impact on a 
model POTW by the proposed federal legislation.  Data acquired from peer 
reviewed journals, manufactures websites, and public documents were used to 
describe and present the types of available PPCP removal technology for a 
comparison.  This data and information was used to interpret and extrapolate the 
usefulness, effectiveness, and cost feasibility of PPCP removal technology for 
POTWs.  A comparison of the PPCP treatment technologies available or utilized 
experimentally was performed.  The data comparison from Table 3 for usefulness 
and economic feasible demonstrated that the implementation of PPCP treatment 
technologies would not be beneficial for POTWs.  The data costs acquired were 
used to extrapolate potential financial impacts and were then deemed 
economically unfeasible for a model POTW.  
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Chapter 4 
 
Results and Discussion 
 An examination of current laws revealed that there are no federal laws 
concerning Pharmaceutical and Personal Care Products and no specific federal 
agency that directly regulates Pharmaceutical and Personal Care Products in 
wastewater.  The proposed federal legislation of S. 1005, H.R. 1262 and H.R. 
1145 would create a regulatory possibility; but currently all proposed federal 
legislation starts with studies creation so an educated decision can be made 
concerning regulations.  Depending on the results of the studies created by the 
proposed federal legislation, there could be requirements for controlling, 
monitoring, and treatment removal.  How the City of Mesa, Arizona water 
reclamation facilities could be affected by the proposed federal legislation is 
varied depending on the requirements of the outcomes of the studies.  
 After examining the potential financial effects of different treatment 
technologies and prevention practices on POTWs due to proposed federal 
legislation there were several possible impacts.  The first impact of proposed 
federal legislation concerning PPCPs on the City of Mesa, AZ water reclamation 
facilities would be the need for an initial water sampling survey to document 
existing PPCPs entering and exiting in their POTWs.  Currently the City of Mesa, 
AZ water reclamation facilities do not test for PPCPs in the influent or effluent 
from their water reclamation plants at any of their three facilities.  The City of 
Mesa receives most of its water from Salt River Project canals (SRP), Central 
Arizona Project canals (CAP) and groundwater wells (City of Mesa Water 
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Resource Department, 2010).  SRP and CAP do test their water supply for PPCPs 
(Chiu, Westerhoff, Herckes, & Masles, 2009).  Since some of the effluent waters 
from all three water reclamation facilities are recharged back or reused at 
locations that would come in contact with a water of the U.S.  The City of Mesa’s 
water reclamation facilities would have an initial expense of testing their influent 
and effluent waters for PPCPs; if such legislation generates regulatory 
requirements, for documentation of existing PPCPs.   
The staff at the three facilities: GWRP, NWWRP, and SWRP, could do 
the initial sampling from their current compliance sampling sites of entry to each 
facility and each of its facilities respective effluent outfall points.  The sampling 
costs would run 1 eight hour day of sampling at $17 an hour per sampling 
technician per facility for a total cost of approximately $410 for all three POTWs.  
The City of Mesa would have to have their samples tested by a certified 
laboratory for EPA Method 1694 (for 74 PPCPs), EPA Method 1698 (for 27 
steroids-hormones), and EPA Method 1699 (for 60 pesticides).  The results of this 
water survey would document existing PPCPs and help to determine necessary 
steps.   
Once the sampling has been done by the staff of the City of Mesa, Arizona 
water reclamation facilities, then the samples would have to be sent to a 
commercial certified laboratory.  The cost for testing per sample would be 
approximately $2200-$2400 (Kissinger, 2011) (Redman, 2011).  The City of 
Mesa, Arizona would sample the influent and effluent of each POTW thus 6 total 
sampling locations: SWWRP has two, GWRP has two, and NWWRP has two. 
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Thus an initial testing for all three facilities could run about $13,200-$14,400 for 
6 samples plus transportation costs for delivery of samples.  Delivery of samples 
to an out-of-state laboratory could cost additional hundreds of dollars due to the 
cost of sending heavy 1L amber bottles in coolers by FedEx or UPS. 
A case study was performed on the City of Mesa, Arizona wastewater 
treatment department that documented and examined the existing infrastructure to 
demonstrate what changes might be needed if the prevention, monitoring, or 
treatment of PPCPs becomes a regulatory necessity.  The results of the federal 
proposed legislative studies created will result in different impacts on POTWs.  
 If preventing or controlling PPCPs becomes required then The City of 
Mesa, Arizona Water reclamation facilities would have to take steps to prevent 
PPCPs from entering the wastewater stream.  The multiple barriers concept 
principle to prevent the introduction of the pollutant is preferred to treatment.  
However, the complete prevention of PPCPs from entering a wastewater 
collection system is not feasible due to the excretion of pharmaceuticals by 
humans making prevention a more economical option.  Investigating options to 
prevent PPCPs would cost less than treatment since economically viable options 
do not exist. Programs like a Household Take-back pharmaceutical program could 
be implemented to prevent the PPCP from entering wastewater or landfills.  The 
City of Mesa could expand their currently existing Household Take-back 
programs to allow for more opportunity for the public to drop off PPCPs.  The 
City of Mesa currently has four different Household Take-back events a year but 
could be expanded to monthly or weekly events to help prevent PPCPs from 
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entering wastewater collection systems.  The cost of having more events for the 
City of Mesa would involve staffing and disposal or recycling of acquired PPCPs.  
Public service announcements could be employed to notify the general public of 
proper disposal methods and of dates and locations of take-back programs.  
Television and radio announcement would help to educate and inform the 
residents of the City of Mesa how the city recommends disposal of PPCPs.  The 
City of Mesa does advertise on their website and at the Household Take-back 
events how to properly handle PPCPs.  Another possibility of controlling the 
introduction of PPCPs into the wastewater stream is requiring hospitals to utilize 
other methods of disposing of unused or expired pharmaceuticals instead of 
untreated disposal into the wastewater collection systems.  All of these types of 
prevention programs would vary in costs for the City of Mesa, Arizona to set up 
and implement.  Consumer awareness and education would help The City of 
Mesa place a barrier for the PPCPs potential contamination.  
The implementation of monitoring as a barrier of PPCPs would require the 
POTWs to do several things.  The City of Mesa, Arizona would have to sample 
and test their influent and effluent from their wastewater treatment facilities.  
Currently for compliance testing, the three water reclamation facilities have 
sampling sites: one before entering the treatment facility and at each of their 
respective outfalls.  If monitoring of PPCPs was required by the City of Mesa 
then sampling could be done at the same time they do their current monthly 
compliance sampling at the same sampling sites.  All three tests: EPA methods 
1694, 1698, and 1699, can be sampled as grab samples or by automatic sampling 
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machines in1L amber bottles.  The staff of the City of Mesa water reclamation 
facilities could perform the sampling.  The testing of the influent would describe 
the types of PPCPs and concentration levels of the PPCPs entering the three 
wastewater reclamation plants.  Testing on the effluent would describe what 
PPCPs are able to pass through the treatment processes and at what 
concentrations.  Monitoring of PPCPs could require the City of Mesa, Arizona to 
incur test set-up costs, sampling costs and testing costs.  The cost of sampling 
supplies would also be incurred if performed in-house unless the testing is sent 
out to a commercial laboratory which usually provides prepared and properly 
preserved bottles. 
The City of Mesa operates a compliance lab that is a state licensed and 
certified laboratory.  This facility analyzes samples of their drinking water and 
wastewater for operational parameters and regulatory compliance. This facility 
could be utilized to test and monitor for PPCPs in their influent and effluent 
waters.  The City of Mesa, AZ would incur the cost of setting up the tests: EPA 
Method 1694, EPA Method 1698 and EPA Method 1699, sampling, and cost of 
maintaining the testing.  Also the City of Mesa compliance lab would have to 
become licensed to perform EPA Method 1694, EPA Method 1698 and EPA 
Method 1699.  These tests could also be sampled by The City of Mesa water 
reclamation staff and submitted to a certified commercial laboratory for testing.  
Most commercial laboratories will provide the sampling supplies but The City of 
(Redman, 2011)Mesa would incur transportation costs of getting samples to the 
laboratory as well as testing costs.  As previously stated, PPCP testing can 
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roughly cost between $2200-$2400 per sample (Kissinger, 2011) (Redman, 2011) 
at a commercial laboratory.  The cost to set-up and maintain the EPA methods for 
PPCP testing at the compliance laboratory would be quite expensive.  The cost of 
equipment and accessories (~$200,000), staff (~$100,000), and sampling supplies 
(~$1000) needs to test for PPCPs could be estimated in the hundreds of thousands 
of dollars.  If the regulations require a monthly sample for each entry point and 
exiting point per POTW site then it would be more economical in the long term to 
set-up the EPA methods at their current compliance laboratory.  If monthly 
monitoring is required then a cost comparison between licensing and maintenance 
versus external laboratory testing should be evaluated. 
The treatment of PPCPs by wastewater treatment plants is the most costly 
and possibly the most difficult requirement.  The multiple barriers concept at the 
wastewater treatment level of the water cycle would employ the most effective 
treatment processes available.  Most of the POTWs in the United States are only 
treating their wastewater to a secondary standard so upgrading their systems 
would be costly.  The City of Mesa, Arizona does reclaim or reuse much of their 
wastewater effluent so they already treat their wastewater using a tertiary 
treatment standard.  Unfortunately for wastewater treatment of PPCPs by POTWs 
none of the technologies presented were realistically viable, refer to Table 3.  All 
the technologies were excessively expensive.  The capital costs and operating 
costs for all technologies would drive the cost for the consumer to astronomical 
levels making it unfeasible for a municipality to implement.  All removal 
efficiency data was calculated under specific laboratory conditions or pilot POTW 
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program standards making it difficult to extrapolate to a typical POTW.  These 
technologies might be feasible for drinking water treatment due to the 
characteristics of influent versus wastewater influent. 
Table 3: Summary of Technology Findings 
      
Technology Costs 
Cons/Difficulties for 
Wastewater 
      
NF 
Capital costs of $0.30-0.50 per 
1000 gal. treated (for drinking 
water)  Expensive filter costs 
    Excessive membrane fouling 
    High operating costs 
    
High levels of organics make it 
not suitable for wastewater. 
MBR 
Capital costs of $7-20 per gallon 
treated  
Capital and operating costs are 
high 
  
Operating costs of $1.23-1.77 per 
1000 gal. treated 
Long solids retention time 
required. 
    
Excessive membrane fouling, 
membrane cleaning, and 
eventual membrane 
replacement. 
AOP 
Capital costs of $1.3 million-1.7 
million  
Capital and operating costs are 
high 
  
Operating costs of $0.86-4.47 per 
1000 gal. treated  
High TOC levels prevent  
efficiency 
      
GAC 
Median treatment costs $0.60 per 
gal. treated (for drinking water) 
Suspended Solids concentration 
too high 
  
Median operating costs $1.10 per 
gal. treated (for drinking water) 
Wastewater purity too low to be 
efficient 
 
 
 If the requirement to treat for removal of PPCPs becomes necessary then 
the City of Mesa, Arizona may incur excessive costs to upgrade, operate, and 
maintain treatment processes at their three treatment plants.  The City of Mesa, 
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Arizona has suggested that they would consider adding GAC filtration system to 
their reclamation plants for physical removal of PPCPs (City of Mesa, Arizona, 
2011).  The Granular Activated Carbon filtration may seem to be the best option 
due to its more economical cost and removal efficiency at the drinking water level 
but this study found no truly economical means of wastewater treatment for 
PPCPs.  The inclusion of GAC filtration at the drinking water facility may be 
beneficial for removal of PPCPs but not in wastewater treatment.   The City of 
Mesa, Arizona treats 162 MGD of surface water at two water treatment facilities 
for which nanofiltration or GAC may be considered for use as a barrier for 
PPCPs.  However a sampling survey of the influent and effluent for PPCPs at 
Mesa’s three water reclamation plants would provide a more accurate assessment 
of the necessary requirements for changes.  The influent analysis and effluent 
analysis would document what PPCPs are making it through the current treatment 
processes and at what concentrations.  These two assessments combined would 
help determine what treatment processes could be best employed for each of the 
three water reclamation plants, if necessary and if costs were not a consideration. 
The City of Mesa states that technologies under investigation for removal 
of PPCPs are membranes and GAC systems for physical removal of compounds 
and ozone or UV for disinfection which can break down some PPCP compounds 
(City of Mesa, 2011).  Currently, all three of the water reclamation facilities 
employ some form of tertiary filtration methods along with systems available for 
disinfection. All three filtration methods: traveling bridge filtration, dual media 
filtration and rotating cloth media filtration, employed at the City of Mesa water 
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reclamation plants are all capable of producing the high quality effluent standards 
needed for reuse of wastewater.  If legislation or regulation concerning treatment 
or removal of PPCPs becomes necessary, The City of Mesa may not necessarily 
need to upgrade any systems depending on what appears in the influents and 
effluents. Since this study did not find any viable options for wastewater 
treatment by POTWs of PPCPs for the City of Mesa to utilize, the use of 
prevention and control methods would be more economically feasible.   
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Chapter 5 
Conclusions 
This study described the current federal laws and regulations concerning 
Pharmaceutical and Personal Care Products and proposed legislature for Publicly 
Owned Treatment Works.  It was found that there are no laws or any specific 
agency that directly regulate Pharmaceutical and Personal Care Products by 
POTWs.  The proposed federal legislation of S. 1005, H.R. 1262 and H.R. 1145 
would create a regulatory possibility. However, all the currently proposed federal 
legislations concerning PPCPs would simply create studies.  These PPCPs studies 
would provide educated information for making decisions concerning regulations 
and laws.  Ultimately though, the proposed federal legislation concerning PPCPs 
for POTW would require no monitoring, recordkeeping, or establishment of 
treatment standards or end of pipe discharge standards. 
An objective was to examine the impact of proposed federal legislation 
concerning the removal of Pharmaceutical and Personal Care Products from 
wastewater by using the City of Mesa POTWs as a model U.S. POTW system. 
Ultimately, if preventing, monitoring, and treatment become a requirement for the 
City of Mesa’s POTWs they could face significant financial and technological 
challenges.  However, initially the proposed legislation would require no changes 
by POTWs until the completion of results of the studies initiated from legislation.  
Another objective was to examine the financial effects of implementation 
of different treatment technologies and prevention practices.  The costs for the 
different technologies and prevention practices varied dramatically.  Controlling 
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or preventing PPCPs requires the City of Mesa, Arizona Water reclamation 
facilities to take steps to prevent PPCPs from entering the wastewater stream with 
programs like a Household Take-back pharmaceutical program and Public 
Service announcements.  Even though the City of Mesa, Arizona would incur 
costs to implement significant increases in the number of Household Take-back 
events it is nothing in comparison to the lack of treatment options and costs of 
installation, operating and maintaining treatment technologies.  The monitoring 
by the City of Mesa would require sampling and expensive testing.  Treatment 
removal of PPCPs by the City of Mesa, Arizona would be limited by options and 
the expense.   
Ultimately, this study found that PPCP contamination could not be 
eliminated completely due to the majority of PPCPs are introduced by the 
excretion of PPCPs into wastewater collection systems.  Although some 
technologies are available they are limited by costs and technology challenges for 
POTWs.  The best possible option of limiting PPCP contamination is by 
preventing the introduction of PPCPs altogether. 
 
Future Recommendations for Study 
 More studies should be performed to develop Nanofiltration, MBR, AOP 
systems, and GAC technologies for removal of PPCPs by POTWs. 
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 Public service announcements and education should be done for the 
general public to prevent intentional and unintentional contamination of 
wastewater, water supply and landfills. 
 More studies should be performed to determine the impact on human 
health by the long term ingestion of Pharmaceutical and Personal Care 
Products at low concentrations. 
 More studies should be conducted on agricultural crops that use reclaimed 
water and biosolids to determine if there are any PPCPs migrating into 
crops. 
  The monitoring of wastewater influent and effluent for PPCPs should be 
conducted to assess the need for control and possible prevention of 
contamination of aquatic environments. 
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APPENDIX 
 
Description of Wastewater Treatment at City of Mesa Existing POTWs 
Northwest Water Reclamation Plant (NWWRP) 
The Northwest Water Reclamation Plant is an 18 MGD design treatment 
capacity wastewater reclamation plant located at 960 North Riverview, Mesa, 
Arizona 85201 in the northwest corner of the City of Mesa servicing 
approximately 120,000 residents. Figure 8 shows the location of NWWRP in the 
City of Mesa, Arizona.  NWWRP has an AZPDES permit (AZ0024031) from 
Arizona for discharges into the Salt River and a NPDES permit (AZ0024627) 
with the US EPA for discharge outfall onto Salt River Pima Maricopa Indian 
Community tribal land. Other permits required by Arizona are an Aquifer 
Protection Permit (P100369) and a Reuse permit (R1003694). The tertiary treated 
effluent from the NWWRP is discharged to two recharge sites and to the Salt 
River.  NWWRP currently produces 13,000 acre-feet of water yearly but is 
projected to produce around 16,500 acre-feet of water yearly of reclaimed water 
(City of Mesa Utilities Department Resources Division, 2004). 
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Figure 8: Location of Northwest Wastewater Reclamation Plant (U.S. 
Environmental Protection Agency, 2011)  
  
The preliminary treatment performed on the incoming flow includes 
mechanical climber screens, grit removal and a grinding pump. Other processes 
performed on the influent are primary sedimentation, activated sludge with 
aerated and anoxic zones for biological nitrogen removal, secondary clarification, 
dual media tertiary filtration, and disinfection by ultraviolet (UV) light with 
chlorination as a back-up system (Hetherington, Permit Application Arizona 
Pollutant Discarge Elimination System (AZPDES) Form 2A, 2010). Effluent 
discharged to the Salt River is also treated with dechlorination (AWWA Research 
Foundation and U.S. EPA, 2001).   Dechlorination is used to prevent effluent 
from releasing toxic levels of residual chlorine into the aquatic environment (U.S. 
Environmental Protection Agency, 2000). An aerial view of the facility is seen in 
figure 9. 
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Figure 9: Aerial view of the NWWRP facility (City of Mesa, Arizona, 2011) 
Southeast Water Reclamation Plant (SEWRP) 
The Southeast Water Reclamation Plant is an 8 MGD design treatment 
capacity water reclamation plant located at 6308 E. Baseline Rd, Mesa, AZ 85206 
on the Superstition Springs Golf Course servicing approximately 100,000 
residents (Arizona Department of Environmental Quality, 2009). Figure 10 shows 
the location of SEWRP in the City of Mesa, Arizona. SEWRP has an AZPDES 
permit (AZ0025151) from Arizona for discharges. Effluent from the SEWRP is 
used for pond replenishment, golf course and landscape irrigation, and 
agriculture. The SEWRP is expected to ultimately reach approximately 11,500 
acre-feet per year of reclaimed water (City of Mesa Utilities Department 
Resources Division, 2004). 
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Figure 10: Location of Southeast Wastewater Reclamation Plant (U.S. 
Environmental Protection Agency, 2011) 
 
The treatment performed on the influent flow includes headworks with 
screening and grit removal. The processes performed on the influent are primary 
sedimentation, aeration basins for nitrification and denitrification as well as 
nutrient removal, secondary clarification, tertiary filtration by traveling bridge 
filters, and disinfection by hypochlorite disinfection system and a ultraviolet (UV) 
disinfection system as a back-up system (Arizona Department of Environmental 
Quality, 2009). This facility also maintains a dechlorination system for use prior 
to discharging into East Maricopa Floodway.  An aerial view of the facility is 
seen in figure 11. 
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Figure 11: Aerial view of the SEWRP facility (Wikimapia, 2010) 
Greenfield Water Reclamation Plant (GWRP) 
The Greenfield Water Reclamation Plant is a thirty acre 16 MGD design 
treatment capacity water reclamation plant located at 4400 South Greenfield Rd, 
Gilbert, AZ 85296 in the Town of Gilbert, Arizona. Greenfield Water 
Reclamation Plant is co-owned by the City of Mesa with the Town of Gilbert and 
the Town of Queen Creek and has a combined service population of 160,000 
residents (Hetherington, Permit Application Arizona Pollutant Discarge 
Elimination System (AZPDES) Form 2A, 2009). Figure 12 shows the location of 
GWRP in the Town of Gilbert, Arizona. The City of Mesa handles the daily 
operations and maintenance of the facility. The facility has a planned treatment 
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capacity increase to 52 MGD with the City of Mesa planned portion to be 
24MGD. GWRP has an AZPDES permit (AZ0025241) from Arizona for 
discharges of effluent into East Maricopa Floodway, a tributary of the Gila River. 
Effluent is also pumped to Gila River Indian Community for reuse in agriculture. 
All the reclaimed water produced from the GWRP will be delivered by pipeline to 
the Gila River Indian Community for agricultural uses (City of Mesa Utilities 
Department Resources Division, 2004). Under a Reclaimed Water Exchange 
Agreement with the Gila River Indian Community, the City of Mesa will receive 
CAP water in exchange for potable purposes (City of Mesa Utilities Department 
Resources Division, 2004). 
 
Figure 12: Location of Greenfield Water Reclamation Plant (U.S. Environmental 
Protection Agency, 2011). 
The treatment performed on the incoming flow includes headworks with 
bar screens, grinders and grit removal. The processes performed on the influent 
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are primary clarification, anoxic and aeration basins for nitrification-
denitrification, secondary clarification, tertiary filtration (rotating cloth disk 
filters), and ultraviolet (UV) disinfection (Arizona Department of Environmental 
Quality, 2010). The facility also maintains anaerobic sludge digesters, centrifuges 
for sludge thickening and dewatering, and an effluent pump station. There are 
plans to upgrade the disinfection system to a hypochlorite system and a 
dechlorination system is in the works. Figure 13 provides an aerial view of this 
facility. 
 
Figure 13: Aerial view of the GWRP facility (Wikimapia, 2011). 
 
 
73 
 
 The purpose of this section was to document the current infrastructure that 
exists for the three POTWs owned and operated by the City of Mesa.  This was 
used to demonstrate what changes might be needed if the prevention, monitoring, 
or treatment of PPCPs becomes a regulatory necessity.   
 
 
 
 
 
 
 
